Exploration and Validation of a Novel Inflammatory Response-Associated Gene Signature to Predict Osteosarcoma Prognosis and Immune Infiltration

References

• Beck O, Paret C, Russo A, et al. Safety and activity of the combination of ceritinib and dasatinib in osteosarcoma. Cancers. 2020;12(4):793. doi:10.3390/cancers12040793
   PubMed Web of Science ®Google Scholar
• Ritter J, Bielack SS. Osteosarcoma. Ann Oncol. 2010;21 Suppl 7:vii320–325. doi:10.1093/annonc/mdq276
   PubMed Web of Science ®Google Scholar
• Anderson ME. Update on survival in osteosarcoma. Orthop Clin North Am. 2016;47(1):283–292. doi:10.1016/j.ocl.2015.08.022
   PubMed Web of Science ®Google Scholar
• Kansara M, Teng MW, Smyth MJ, Thomas DM. Translational biology of osteosarcoma. Nat Rev Cancer. 2014;14(11):722–735. doi:10.1038/nrc3838
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. doi:10.1016/S0140-6736(00)04046-0
   PubMed Web of Science ®Google Scholar
• Sipos F, Firneisz G, Műzes G. Therapeutic aspects of c-MYC signaling in inflammatory and cancerous colonic diseases. World j Gastroenterol. 2016;22(35):7938–7950. doi:10.3748/wjg.v22.i35.7938
   PubMed Web of Science ®Google Scholar
• Dvorak HF, Underhill LH, Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650–1659. doi:10.1056/NEJM198612253152606
   PubMed Web of Science ®Google Scholar
• Jettoo P, Tan G, Gerrand CH, Rankin KS. Role of routine blood tests for predicting clinical outcomes in osteosarcoma patients. J Orthop Surg Res. 2019;27(2):2309499019838293. doi:10.1177/2309499019838293
   Google Scholar
• Li X, Tian F, Wang F, Li Y. Serum C-reactive protein and overall survival of patients with osteosarcoma. Tumor Biol. 2015;36(7):5663–5666. doi:10.1007/s13277-015-3240-6
   PubMedGoogle Scholar
• Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493–503. doi:10.1016/S1470-2045(14)70263-3
   PubMed Web of Science ®Google Scholar
• Lin Z, Xu Q, Miao D, Yu F. An inflammatory response-related gene signature can impact the immune status and predict the prognosis of hepatocellular carcinoma. Front Oncol. 2021;11:644416. doi:10.3389/fonc.2021.644416
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang Z, Zhang G, et al. Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma. Cancer Lett. 2020;479:31–41. doi:10.1016/j.canlet.2020.03.016
   PubMed Web of Science ®Google Scholar
• Vrieze SI. Model selection and psychological theory: a discussion of the differences between the Akaike information criterion (AIC) and the Bayesian information criterion (BIC). Psychol Methods. 2012;17(2):228–243. doi:10.1037/a0027127
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Yoshihara K, Shahmoradgoli M, Martínez E, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. doi:10.1038/ncomms3612
   PubMed Web of Science ®Google Scholar
• Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453–457. doi:10.1038/nmeth.3337
   PubMed Web of Science ®Google Scholar
• Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA. Profiling tumor infiltrating immune cells with CIBERSORT. Methods Mol Biol. 2018;1711:243–259.
   PubMedGoogle Scholar
• Zhang W, Zhao JM, Lin J, et al. Adaptive fibrogenic reprogramming of osteosarcoma stem cells promotes metastatic growth. Cell Rep. 2018;24(5):1266–1277.e1265. doi:10.1016/j.celrep.2018.06.103
   PubMed Web of Science ®Google Scholar
• Fokas E, Engenhart-Cabillic R, Daniilidis K, Rose F, An HX. Metastasis: the seed and soil theory gains identity. Cancer Metastasis Rev. 2007;26(3–4):705–715. doi:10.1007/s10555-007-9088-5
   PubMed Web of Science ®Google Scholar
• Han Y, Guo W, Ren T, et al. Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Lett. 2019;440–441:116–125. doi:10.1016/j.canlet.2018.10.011
   PubMed Web of Science ®Google Scholar
• Dai Y, Liu M, Lei L, Lu S. Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: a systematic review and meta-analysis. Medicine. 2020;99(38):e21840. doi:10.1097/MD.0000000000021840
   PubMed Web of Science ®Google Scholar
• Templeton AJ, Ace O, McNamara MG, et al. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol, Biomarkers Prevent. 2014;23(7):1204–1212. doi:10.1158/1055-9965.EPI-14-0146
   PubMed Web of Science ®Google Scholar
• Gu L, Li H, Chen L, et al. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget. 2016;7(22):31926–31942. doi:10.18632/oncotarget.7876
   PubMedGoogle Scholar
• Liu T, Fang XC, Ding Z, Sun ZG, Sun LM, Wang YL. Pre-operative lymphocyte-to-monocyte ratio as a predictor of overall survival in patients suffering from osteosarcoma. FEBS Open Bio. 2015;5:682–687. doi:10.1016/j.fob.2015.08.002
   PubMed Web of Science ®Google Scholar
• Liu B, Huang Y, Sun Y, et al. Prognostic value of inflammation-based scores in patients with osteosarcoma. Sci Rep. 2016;6:39862. doi:10.1038/srep39862
   PubMed Web of Science ®Google Scholar
• Xia WK, Liu ZL, Shen D, Lin QF, Su J, Mao WD. Prognostic performance of pre-treatment NLR and PLR in patients suffering from osteosarcoma. World J Surg Oncol. 2016;14:127. doi:10.1186/s12957-016-0889-2
   PubMed Web of Science ®Google Scholar
• Zuckerman LM, Frames WL, Elsissy JG, et al. The effect of non-steroidal anti-inflammatory drugs on osteosarcoma cells. Eur Rev Med Pharmacol Sci. 2019;23(6):2681–2690. doi:10.26355/eurrev_201903_17416
   PubMed Web of Science ®Google Scholar
• Liu B, Yan S, Qu L, Zhu J. Celecoxib enhances anticancer effect of cisplatin and induces anoikis in osteosarcoma via PI3K/Akt pathway. Cancer Cell Int. 2017;17:1. doi:10.1186/s12935-016-0378-2
   PubMed Web of Science ®Google Scholar
• Jiang Y, Wang X, Cheng Y, et al. Associations between inflammatory gene polymorphisms (TNF-α 308G/A, TNF-α 238G/A, TNF-β 252A/G, TGF-β1 29T/C, IL-6 174G/C and IL-10 1082A/G) and susceptibility to osteosarcoma: a meta-analysis and literature review. Oncotarget. 2017;8(57):97571–97583. doi:10.18632/oncotarget.18813
   PubMedGoogle Scholar
• Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32(19–20):1267–1284. doi:10.1101/gad.314617.118
   PubMed Web of Science ®Google Scholar
• Heymann MF, Lézot F, Heymann D. The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma. Cell Immunol. 2019;343:103711. doi:10.1016/j.cellimm.2017.10.011
   PubMed Web of Science ®Google Scholar
• Cao H, Quan S, Zhang L, Chen Y, Jiao G. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma. Oncol Lett. 2021;21(5):391. doi:10.3892/ol.2021.12652
   PubMed Web of Science ®Google Scholar
• Deng C, Xu Y, Fu J, et al. Reprogramming the tumor immunologic microenvironment using neoadjuvant chemotherapy in osteosarcoma. Cancer Sci. 2020;111(6):1899–1909. doi:10.1111/cas.14398
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56–61. doi:10.1126/science.aaa8172
   PubMed Web of Science ®Google Scholar
• Muraro M, Mereuta OM, Saglio F, et al. Interactions between osteosarcoma cell lines and dendritic cells immune function: an in vitro study. Cell Immunol. 2008;253(1–2):71–80. doi:10.1016/j.cellimm.2008.05.002
   PubMed Web of Science ®Google Scholar
• Gu-Trantien C, Loi S, Garaud S, et al. CD4+ follicular helper T cell infiltration predicts breast cancer survival. J Clin Invest. 2013;123(7):2873–2892. doi:10.1172/JCI67428
   PubMed Web of Science ®Google Scholar
• Gao W, Zhou J, Ji B. Evidence of interleukin 21 reduction in osteosarcoma patients due to PD-1/PD-L1-mediated suppression of follicular helper T cell functionality. DNA Cell Biol. 2017;36(9):794–800. doi:10.1089/dna.2017.3669
   PubMed Web of Science ®Google Scholar
• Ueda T, Healey JH, Huvos AG, Ladanyi M. Amplification of the MYC gene in osteosarcoma secondary to paget’s disease of bone. Sarcoma. 1997;1(3–4):131–134. doi:10.1080/13577149778209
   PubMedGoogle Scholar
• Chen D, Zhao Z, Huang Z, et al. Super enhancer inhibitors suppress MYC driven transcriptional amplification and tumor progression in osteosarcoma. Bone Res. 2018;6:11. doi:10.1038/s41413-018-0009-8
   PubMed Web of Science ®Google Scholar
• Han G, Wang Y, Bi W. C-Myc overexpression promotes osteosarcoma cell invasion via activation of MEK-ERK pathway. Oncol Res. 2012;20(4):149–156. doi:10.3727/096504012X13522227232237
   PubMed Web of Science ®Google Scholar
• Xiong W, Wang H, Lu L, et al. The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival. J Transl Med. 2017;15(1):234. doi:10.1186/s12967-017-1336-z
   PubMedGoogle Scholar
• Chen X, Eksioglu EA, Carter JD, et al. Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritis. PLoS One. 2015;10(2):e0115116. doi:10.1371/journal.pone.0115116
   PubMed Web of Science ®Google Scholar
• Huang YL, Chen ST, Liu RS, et al. CLEC5A is critical for dengue virus-induced osteoclast activation and bone homeostasis. J Mol Med. 2016;94(9):1025–1037. doi:10.1007/s00109-016-1409-0
   PubMed Web of Science ®Google Scholar
• Lu J, Chen W, Liu H, Yang H, Liu T. Transcription factor CEBPB inhibits the proliferation of osteosarcoma by regulating downstream target gene CLEC5A. J Clin Lab Anal. 2019;33(9):e22985. doi:10.1002/jcla.22985
   PubMed Web of Science ®Google Scholar